Bausch Health Companies | VRX - Umsatzerlöse

Aktienkurs
7.89
Täglich Wechseln
0.12 1.54%
Monatlich
14.68%
Jährlich
31.28%
Q2 Prognose
7.59




Der Umsatz Veränderung Datum
Amgen USD 9.9B 340M 2025-12
ANI Pharmaceuticals USD 247.06M 19.25M 2025-12
Aurora Cannabis CAD 94.19M 3.82M 2025-12
Bausch Health Companies USD 2.8B 120M 2025-12
Biogen USD 2.28B 250M 2025-12
Bristol-Myers Squibb USD 12.5B 300M 2025-12
Canopy Growth CAD 74.54M 7.86M 2025-12
Corcept Therapeutics USD 202.12M 5.48M 2025-12
Danaher USD 6.84B 790M 2025-12
Drreddys Laboratories INR 87.27B 1.82B 2025-12
Eli Lilly USD 19.3B 1.7B 2025-12
Gilead Sciences USD 7.93B 130M 2025-12
Nektar Therapeutics USD 21.81M 2.32M 2025-12
Novo Nordisk DKK 79.14B 4.16B 2025-12
Pacira USD 196.87M 17.35M 2025-12
Perrigo USD 1.11B 70M 2025-12
Phibro Animal Health USD 373.91M 10.02M 2025-12
Prestige Brands USD 283.44M 9.34M 2025-12
Supernus Pharmaceuticals USD 211.6M 19.5M 2025-12
Vertex Pharmaceuticals USD 3.19B 110M 2025-12
Zoetis USD 2.4B 0 2025-12